吉贝尔 (688566)

Jiangsu Jibeier Pharmaceutical Co., Ltd.

KSH

Tags

SSE Corporate Governance IndexGeneric DrugsInnovative DrugsChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareSTAR Market 200 IndexHigh-Performing StocksHepatitis ConceptMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 19943.09
  • Circulating A-Shares(W): 19943.09
  • Earnings Per Share(RMB): 0.9900
  • Net Assets Per Share(RMB): 11.8246
  • Operating Revenue(W RMB): 70443.23
  • Total Profit(W RMB): 22770.01
  • **Net Profit Attributable to Parent(W RMB) **: 19690.42
  • Net Profit Growth Rate(%): 12.80
  • Weighted Return on Equity(%): 8.4600
  • Operating Cash Flow Per Share(RMB): 0.8400
  • Undistributed Profit Per Share(RMB): 3.7269
  • Capital Reserve Per Share(RMB): 6.5977

2. Main Business

The main business covers:

  • Research, production, and sales of tablets, capsules, and eye drops.

3. Company Basic Information

  • Company Name: Jiangsu Jibei'er Pharmaceutical Co., Ltd.
  • Listing Date: 2020-05-18
  • Industry: Pharmaceutical Manufacturing
  • Address: High-tech Industrial Development Zone, Zhenjiang City, Jiangsu Province
  • Website: https://www.jbepharm.com/
  • Company Profile: The issuer was established through the overall transformation of Jibei'er Co., Ltd. On September 7, 2014, resolved by the shareholders' meeting of Jibei'er Co., Ltd., the original shareholders of Jibei'er Co., Ltd. acted as promoters. Using the audited net assets of RMB 152.5252 million as of May 31, 2014, by ShineWing, the share capital was converted at a ratio of 1:0.89165577, resulting in a total of 136 million shares with a par value of RMB 1 per share. The non-converted net assets were recorded as capital reserve, and Jibei'er Co., Ltd. was transformed into a joint stock limited company. ShineWing audited the capital contribution for the issuer's restructuring and issued the "Capital Verification Report" XYZH/2014SHA2005. On November 18, 2014, the Jiangsu Zhenjiang Administration for Industry and Commerce issued the "Business License" with registration number 321100400003721 to the company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhenjiang Zhongtian Investment Consulting Co., Ltd. General Legal Person 5440.00 27.28
2 Nantong Huirui Investment Co., Ltd. General Legal Person 2720.00 13.64
3 Nantong Huiji Technology Development Co., Ltd. General Legal Person 1570.00 7.87
4 Shanghai Xuanding Private Fund Management Co., Ltd. - Xuanding Feiyang Private Securities Investment Fund Private Securities Investment Fund 373.00 1.87
5 Guojin Securities - China CITIC Bank - Guojin Securities Jibei'er Executives Participation in Sci-Tech Innovation Board Strategic Placement No. 1 Collective Asset Management Plan General Legal Person 307.65 1.54
6 Caitong Advantage Industry Rotation Hybrid Securities Investment Fund Class A Fund 123.92 0.62
7 GF Healthcare Equity Securities Investment Fund Class A Fund 95.90 0.48
8 Caitong Science and Technology Innovation Hybrid Securities Investment Fund Class A Fund 57.23 0.29
9 Caitong Science and Technology Innovation Theme Flexible Allocation Hybrid Securities Investment Fund (LOF) Fund 50.06 0.25
10 Guolian Medicine and Consumption Hybrid Securities Investment Fund Class A Fund 7.91 0.04

5. Concept Sectors

  • Generic Drugs
  • Hepatitis Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • SSE Governance
  • Sci-Tech Innovation 200

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information